Key Takeaways

• Strategic Brand Acquisition: Listed cosmetics group Warpaint London has acquired the Barry M brand out of administration for £1.4 million in cash. The acquisition secures Barry M's presence in over 1,300 stores, including major units in Boots, Superdrug, and Tesco.
• Asset-Only Deal: The transaction includes Barry M’s intellectual property (IP), stock, and order book, but strictly excludes its manufacturing capabilities and liabilities.
• Job Losses: As manufacturing facilities were not part of the deal, Barry M's London factory is expected to close, putting approximately 100 jobs at risk.

Administration Details

Barry M filed a notice of intention to appoint administrators on last week, following a period of intense financial pressure. Subject to court approval, administrators from Begbies Traynor secured the sale to Warpaint London on 9 February 2026.

The deal was executed as a rapid rescue to preserve the brand's market position. By acquiring only the IP and stock, the buyer avoided the mounting debt and uncompetitive manufacturing costs that triggered the insolvency.

Business Details

Founded in 1982 by Barry Mero, Barry M is a London-based pioneer of ethical, cruelty-free, and vegan beauty products. The brand became a staple of the UK high street, known primarily for its vibrant nail varnishes and affordable cosmetics.

• Financial Snapshot (Feb 2024): The company reported a turnover of £17.4 million and a pre-tax profit of £172,000.
• Net Assets: At the time of its last full filing, net assets totalled £6.7 million, with current assets valued at £10.6 million.
• Distribution Power: The brand maintains one-metre-plus stands in over 1,300 retail locations, including 650 Superdrug and 420 Boots stores.

Reasons for Administration

Despite its strong retail presence and a significant rebrand aimed at younger consumers last year, Barry M succumbed to a "perfect storm" of economic pressures:

• Geopolitical Impact: The company warned that international tensions had significantly inflated raw material and supply chain costs.
• Manufacturing Inefficiency: Maintaining a 45,000-square-foot factory in London became increasingly uncompetitive compared to rivals using overseas production.
• Macroeconomic Headwinds: Like much of the sector in 2025/26, the brand struggled with soaring energy costs and a "challenging consumer environment" that dampened discretionary spending

Strategic Insight for Distressed Business Buyers

The acquisition of Barry M highlights how a distressed business can be revitalised through a targeted asset purchase:

• IP Over Infrastructure: Warpaint London’s decision to exclude manufacturing capabilities demonstrates a trend in business acquisition where buyers value the "brand authority" and IP over expensive, underperforming fixed assets.
• Market Penetration: For the buyer, this deal offers an "accelerated" route into premium retail channels at a fraction of the cost of organic growth.
• Solvency vs. Brand Value: Barry M remained a popular, revenue-generating brand despite its corporate financial distress, making it a prime target for a group with a stronger balance sheet to absorb its order book.

FAQs

What assets did Warpaint London actually buy? The £1.4 million cash consideration covered Barry M's intellectual property, existing stock, and its current order book.

Will Barry M products still be available in shops? Yes. Warpaint intends to use the acquisition to grow its penetration into UK retail channels, meaning Barry M stands in stores like Boots and Superdrug are expected to remain.

Why were the manufacturing staff not included in the deal? Warpaint London already has established supply chains for its other brands, such as W7 and Technic. By excluding the London factory, the buyer avoids the high overheads and liabilities that contributed to Barry M's original insolvency.

What was the impact on Warpaint London’s own financials? The acquisition was announced alongside a trading update where Warpaint projected 2025 revenues of £105 million. However, the group also forecast a 12% drop in adjusted EBITDA to £22 million, citing US tariff uncertainty and the closure of a major client, Bodycare.

For more information on similar distressed businesses and key insights on success acquisition strategies, keep following Administration List.